MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transepithelial CDMO Leader
![](https://www.terguspharma.com/wp-content/uploads/2024/07/LinkedIn_Merger.png)
GUILDFORD, United Kingdom and DURHAM, N.C., July 8, 2024 — MedPharm, Ltd., an Ampersand Capital Partners portfolio company, and Tergus Pharma, a Great Point Partners [...]
Tergus Pharma Announces Michael Kane as Chief Executive Officer
![](https://www.terguspharma.com/wp-content/uploads/2022/10/Tergus-CEO.jpg)
Durham, NC – Tergus Pharma, a commercial scale Contract Development and Manufacturing Organization (CDMO) of semi-solid and liquid dosage forms, [...]
Tergus Pharma Makes Key Executive Hires
![](https://www.terguspharma.com/wp-content/uploads/2021/09/DSC_0016.jpg)
DURHAM, N.C. September 8, 2021 — Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO) with proven topical [...]
Tergus Pharma to Participate in ECRM Contract Services Program for OTC Health and Supplements
![](https://www.terguspharma.com/wp-content/uploads/2021/02/Tergus.jpg)
DURHAM, N.C. February 9, 2021 – Tergus Pharma announced today that the company will be participating in ECRM’s virtual trade [...]